Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
INOVIO , a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced ...
Axcelis Technologies, Inc. , a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will showcase its innovative Puriontm platform of ion ...
Eli Lilly strengthens its pipeline with AdvanCell for targeted alpha therapies and partners with OliX to advance OLX75016 for MASH and cardiometabolic diseases.
AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...
The number of clinical trials in which AI designed or repurposed molecules, or targeted diseases, has more than doubled since ...
Two biotechs say they’re using AI to conjure drugs from scratch. Their documents suggest otherwise
A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedicines routinely aggrandize their AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback